A common HIV/AIDS risk reduction strategy among men who have sex with men (MSM) is to limit their unprotected sex partners to those who are of the same HIV status, a practice referred to as serosorting. Decisions to serosort for HIV risk reduction are based on personal impressions and beliefs, and there is limited guidance offered on this community derived strategy from public health services. This paper reviews research on serosorting for HIV risk reduction and offers an evidence-based approach to serosorting guidance. Following a comprehensive electronic and manual literature search, we reviewed 51 studies relating to the implications of serosorting. Studies showed that HIV negative MSM who select partners based on HIV status are inadvertently placing themselves at risk for HIV. Infrequent HIV testing, lack of HIV status disclosure, co-occurring sexually transmitted infections, and acute HIV infection impede the potential protective benefits of serosorting. Public health messages should continue to encourage reductions in numbers of sexual partners and increases in condom use. Risk reduction messages should also highlight the limitations of relying on one's own and partner's HIV status in making sexual risk decisions.
Introduction
Sexual transmission accounts for the vast majority of HIV infections and men who have sex with men (MSM; CDC, 2007) consistently account for a majority of HIV infections in North America and Western Europe. In response to the continued risk of HIV infection among MSM, partner selection strategies to reduce the likelihood of HIV infection have emerged (Parsons et al., 2005) . One such strategy is limiting unprotected sexual partners to those who have the same HIV status or serosorting (Clatts, Goldsamt, & Yi, 2005; Elford, Bolding, & Hart, 2007; Mao et al., 2006; Xia et al., 2006) . Serosorting is a common HIV prevention practice, with 21Á62% of both HIV positive and HIV negative MSM reporting serosorting to reduce HIV transmission risks Golden, Wood, Buskin, Fleming, & Harrington, 2007; Mao et al., 2006; Xia et al., 2006) .
Serosorting practices stem from multiple motivations, most salient of which appear to be intentions to maintain a sense of personal safety while avoiding condom use (Ostrow et al., 2008; Stolte et al., 2006) . Serosorting may also allow for an escape from stigma related to sexual orientation or HIV status and the opportunity to experience sex as a natural behavior. As such, changing community norms and risk perceptions have facilitated the use of protective alternatives in place of condoms. The perceived threat of HIV has decreased with increased HIV treatment optimism and beliefs that HIV treatments eliminate the risk for HIV transmission Sullivan, Drake, & Sanchez, 2007) .
In theory, selecting sex partners of the same HIV status should offer protection against transmission. However, in practice, the protective value of serosorting may be questionable. In this paper we focus on the nuances of partner selection strategies that fall under the rubric of serosorting and explicate the necessary assumptions for serosorting to be effective. To frame our review we define serosorting and its risks differently for (1) people who have tested HIV positive and seek HIV positive partners; and (2) for people who test HIV negative and seek HIV negative sex partners. For HIV positive persons, who can be certain of their HIV status, serosorting can provide benefits. However, unprotected sex between HIV infected persons carries risks, namely HIV superinfection and sexually transmitted infections (STI), that should be considered when making sexual decisions. In contrast, serosorting for persons who test HIV negative does risk new HIV infections. For HIV negative persons, the necessary features of effective serosorting are hinged on accurate knowledge of one's own and partner's HIV status. It is these features that make up the nuances of serosorting that are the focus of this review.
Literature reviewed
We conducted a comprehensive literature search in August 2008 using several search engines and manual searches of journals, with key terms serosorting, HIV status, partner selection, and sexual risk behaviors. Studies differed in their operational definitions of serosorting. For example, some studies defined serosorting by participants explicitly stating that they intentionally limit their unprotected sex partners to those who are of the same HIV status. In contrast, other studies defined serosorting based on sexual behaviors, namely persons who exclusively report having same HIV status, unprotected partners regardless of whether or not they are motivated to select partners based on HIV status. For the purposes of this review, we included studies that employed either an identity-based or behavioral definition of serosorting.
In total, 51 studies were included in the review. These studies either directly investigated serosorting as a preventive practice or provided key information on whether or not people have accurate knowledge of own and partner's HIV status. Overall, we identified 25 studies on the prevalence and/or specific implications of serosorting, eight studies on HIV status disclosure in relation to serosorting, 10 studies on HIV testing related to serosorting, seven studies addressing issues related to STI/HIV coinfection, six studies on HIV superinfection, four studies detailing the impact of acute HIV infection, with several of these studies offering data on more than one aspect of serosorting.
Serosorting among HIV positive MSM
Serosorting as a partner selection strategy has likely occurred largely undefined for many years among HIV positive men and only more recently has been labeled as such and addressed in research. HIV positive men may be motivated to seek out same status partners due to several factors including: altruism Á not wanting to further spread the virus (O'Dell, Rosser, Miner, & Jacoby, 2008), legal concerns around HIV disclosure Á the criminalization of HIV transmission (Galletly & Pinkerton, 2006) , and psycho-social factors Á stigma, fear of rejection, and safe sex fatigue (Remien & Mellins, 2007) . Serosorting can therefore serve an important function in the relationships of many HIV positive MSM. Serosorting allows HIV positive men to remain sexually active and avoid condom use without the risk of infecting others. Moreover, HIV seroconcordance has possibly slowed the number of incident HIV infections (Truong et al., 2006b) .
Although, serosorting among HIV positive MSM can potentially protect against transmitting the virus to uninfected men, nuances of serosorting practices can threaten the health of HIV positive MSM. Because serosorting involves unprotected sexual acts, it is necessary to consider the implications of all factors related to condomless sex that may affect HIV transmission risks or HIV disease progression, particularly HIV status disclosure, STI co-infection, and HIV superinfection (Colfax et al., 2004) . The potential risks and benefits posed by serosorting for HIV positive persons are summarized in Figure 1 .
Serosorting and HIV status disclosure Accurately knowing the HIV serostatus of sexual partners ultimately determines the protective value of serosorting among people who have tested HIV positive. There are, however, barriers to serostatus disclosure, such as stigma and lack of communication skills that seriously impede the effectiveness of serosorting among HIV positive men. It is common for people to make implicit assumptions about their sexual partner's HIV status as opposed to relying on explicit, verbal discussions in which HIV status Explicit disclosure of HIV positive status Partner explicitly discloses HIV positive status
No risk of HIV transmission
Assume partner is HIV positive
Risk of HIV transmission

Certain of own HIV positive status based on test result
No explicit disclosure of HIV positive status Test HIV positive is disclosed. As many as one in three HIV positive MSM engage in unprotected anal intercourse (UAI) without ever disclosing their HIV status to their partners (Ciccarone et al., 2003; Grov et al., 2007; Marks & Crepaz, 2001; Wolitski, Rietmeijer, Goldbaum, & Wilson, 1998) . Some studies have shown that a majority of HIV positive MSM report assuming that the HIV status of their sex partners is HIV positive (Parsons et al., 2006) . Niccolai, Farley, Ayoub, Magnus, and Kissinger (2002) found that the percent agreement between partner's reported HIV status and partner's actual HIV status was less than would be expected by chance (kappa 0(0.06). Inconsistencies between partner's reported HIV status and actual HIV status may result from a confirmation of status bias: individuals assume, based on non-verbal cues, that their partner's HIV status is the same as their own (Suarez & Miller, 2001) .
Risk for STI coinfection and HIV superinfection
STI coinfection
HIV positive men who serosort risk coinfection with STIs, which increases infectiousness and can potentially accelerate HIV disease progression. The extent to which STIs affect HIV disease progression differs for specific pathogens. Repeated exposure to ejaculate during UAI is associated with slight declines in specific immune markers, particularly CD4 cell counts, and is most likely due to STI coinfection (Wiley et al., 2000) . Syphilis has also been linked to both increased blood HIV load and decreased CD4 cells (Buchacz et al., 2004) . Although evidence is somewhat mixed, genital ulcer diseases have been linked to decreased CD4 cells and increased HIV viral load in blood and genital secretions (Cachay et al., 2007; Duffus et al., 2005; Dyer et al., 1998; Kalichman et al., 2007) . In general, non-HIV viral infections appear to hasten HIV viral replication by compromising the immune system (White, Gorrill, & Khalili, 2006) .
HIV superinfection
Once considered only a theoretical risk, the potential for HIV superinfection has now been confirmed (Smith et al., 2004) . HIV superinfection occurs following reinfection with previously unexposed variants of HIV, resulting in recombinant genetic processes. HIV superinfection is of particular concern because it is associated with antiretroviral drug resistance, increased HIV virulence (Cohen & Fauci, 1998) , acceleration of HIV disease, and increased HIV infectiousness (Blackard, Cohen, & Mayer, 2002) . However, HIV superinfection occurs most frequently among HIV positive persons with more recent HIV infection and even among those who are recently infected, superinfection appears to be a rare event (Diaz et al., 2005; Grant et al., 2004; Gross, Porco, & Grant, 2004) .
Serosorting among HIV negative MSM
Although some factors related to serosorting among HIV negative MSM are similar to those of HIV positive MSM, such as the central role of HIV status disclosure in partner selection, the behavioral health implications of serosorting are considerably different. Unlike serosorting among persons who have tested HIV positive, serosorting as a risk reduction practice among HIV negative persons engenders considerable risk for new HIV infections. With the potential for acute infection and an overall lack of HIV testing and explicit HIV status disclosure, serosorting alone can not be relied on for preventing HIV infection. Furthermore, co-occurrence of other STI during possible exposure to HIV further undermines the potential protective value of serosorting for HIV negative men. Figure 2 summarizes the potential risks for HIV transmission among persons who test HIV negative and serosort.
Frequency of HIV testing
The effectiveness of serosorting in reducing HIV transmission risks depends on accurately knowing one's own HIV status and the HIV status of their sex partners. Knowing one's own HIV status requires individuals who engage in unprotected sexual behaviors to frequently test for HIV. Unfortunately, studies have shown that MSM who engage in risk behaviors do test repeatedly but infrequently . The studies summarized in Table 1 suggest that it is nearly impossible for persons who engage in high risk behaviors to ever be certain of their HIV status in part because they do not test often enough. HIV testing is even infrequent among persons at risk who receive services where HIV testing is readily available. For example, in a study of 52,260 STI clinic patients HIV infection was greater among unlinked HIV tests conducted on routinely collected blood specimens than it was among individuals who received voluntary counseling and testing notification (Weinstock, Dale, Linley, & Gwinn, 2002) .
For men at elevated risk, the rate of HIV infection among those who are not aware of their HIV status is alarming. Several studies, including those with large representative samples, such as the Young Men's Survey and the National HIV Behavioral Surveillance system, have shown that HIV infected MSM are often unaware of their HIV positive status AIDS Care 1281 (CDC, 2002; Golden, Brewer, Kurth, Holmes, & Handsfield, 2004; MacKellar et al., 2006a,b) . The CDC's (2005) study of HIV/AIDS in MSM found that among men who were HIV infected and unaware of their HIV status, 42% perceived themselves at low risk for currently being HIV infected or becoming infected. In this same study among men who reported anal intercourse in the past six months, 52% reported not using condoms. The most common reasons for not using condoms included either ''knowing'' they were HIV negative, ''knowing'' their partner was HIV negative, or believing their partner was at low risk for HIV transmission.
As many as half of all persons recently diagnosed with HIV deny having engaged in risk behaviors with any HIV positive or HIV unknown status partners before testing HIV positive (Golden, 2006) . In a retrospective study of recently HIV infected and diagnosed MSM who reported UAI, one in five were certain their sex partner, who was the source of their infection, was HIV negative (Jin et al., 2007) . Increased risk for HIV infection is also associated with engaging in sex with HIV negative partners in longitudinal studies (Koblin et al., 2006) . Misrepresenting HIV status, or falsely disclosing, may also be an important factor in explaining these findings, with one study reporting that among HIV positive individuals, one in five reported telling a sex partner they were HIV negative since being informed of their HIV positive diagnosis (Golden et al., 2007) .
Acute HIV infection and infectiousness
Viral replication during the acute infection stage of HIV disease is significantly higher than during chronic HIV infection (Pilcher et al., 2004) . Acute HIV infection has been linked to increased likelihood of HIV transmission due to increased infectiousness during this period (Wawer et al., 2005) . Further complicating the transmission risk during acute HIV infection is that standard enzyme immunoassays do not detect HIV antibodies during the acute infection phase (Pilcher et al., 2005; Truong et al., 2006a) . When acute infection is considered, individuals who are most infectious may test HIV antibody negative, mistakenly disclose they are HIV negative, and engage in unprotected sex believing that they are not placing their partners at risk (Butler & Smith, 2007) .
Exposure to STI and increased risk for HIV infection
An abundance of research indicates that the presence of both ulcerative (herpes simplex virus (HSV), syphilis) and non-ulcerative (Chlamydia, gonorrhea) STIs is associated with increased risks of HIV infection (Engels et al., 2007; Koblin et al., 2006; Mehta, Ghanem, Rompalo, & Erbelding, 2006) with one review finding a two to five fold increase in HIV transmission risk as a result of STI (Fleming & Wasserheit, 1999) . The presence of an STI leads to an increased likelihood of becoming HIV infected due to exposure of susceptible cells and portal of entry to Figure 2 . Paths for HIV transmission and knowledge of one's own and partner's HIV status among HIV negative MSM who serosort. Á Of the 117 men who tested HIV positive, 32% of these infections occurred among men who serosort. Eaton et al. (2007) The 628 self-reported HIV negative MSM from Atlanta, GA Cross-sectional surveys administered at a gay pride festival Á Around 1/3 of MSM who serosort report the date of their last HIV test as greater than a year ago. Á These men report an average of four sexual partners in the past six months. Jin et al. (2007) The 102 Cross-sectional surveys administered to clients at an outpatient HIV clinics at an STI clinic Á Of MSM, 45% report discussing serostatus with less than half of their partners. Á As number of partners increases serostatus discussion decreases. Koblin et al. (2006) The 4295 Á Of MSM, 10% tested positive and were previously unaware of infection. Á Of MSM, who had never or greater than a year ago been HIV tested, 11% tested HIV positive. Golden (2006) MSM attending STD clinic Cross-sectional data were collected by clinicians as part of routine clinical encounters Á Approximately 50% of new HIV diagnoses among MSM occur among men who denied engaging in UAI with unknown or HIV positive partners. the immune system. Thus, men who serosort place themselves at risk for STI which can ultimately increase their susceptibility to HIV infection (CDC, 1999; Kalichman, DiBerto, & Eaton, 2008) .
Sex w/o condoms is little/no risk for HIV transmission
Conclusions and implications
The implications of partner selection strategies for HIV prevention differ for persons who have tested HIV positive versus those who have tested HIV negative. For HIV positive persons and their HIV positive partners, who are able to openly and accurately disclose their HIV status, serosorting under these circumstances eliminates the risks for new HIV infections. However, it is essential that disclosure be explicit rather than implicit, and that both HIV positive partners be aware of the risks to their health posed by coinfection with other STI and potentially superinfection. Furthermore, condom use remains the most effective option for protecting one's health. For individuals who have tested HIV negative, there is a protective value in serosorting when it is practiced under limited conditions. For couples who test HIV negative within the context of a mutually monogamous relationship, engaging in unprotected intercourse poses little or no risk for HIV infection. However, for HIV negative MSM who have concurrent or multiple sex partners, serosorting possesses limitations that impede its potential for risk reduction. HIV status of sex partners is often assumed rather than openly discussed, HIV testing is typically infrequent, and considerable risk for HIV since last test is commonly reported. It is important to highlight that HIV testing is insufficient for providing protective knowledge of HIV status when risk behavior continues. Given that risk behaviors may actually increase with serosorting coupled with the biological sequelae of acute infections, it is unlikely that HIV negative MSM who serosort could ever test for HIV frequently enough for testing to provide protection against HIV infection.
Although serosorting appears to be flawed for preventing HIV infection among HIV negative MSM, combing this practice with other measures of prevention may offer opportunities for HIV risk reduction. By serosorting MSM are clearly seeking to meet sexual needs while protecting themselves from HIV. Serosorting combined with strategies, such as condom use, strategic positioning, early withdrawal, and negotiated safety may assist MSM in taking rational and calibrated risks, a concept referred to as seroadapting (Le Talec & Jablonski, 2008) . Although, with the exception of condom use, these methods alone are probably not highly effective, together they may lead to overall reductions in risk.
Content for interventions that focus on serosorting
should emphasize the necessity of explicit HIV status disclosure discussions, including emphasizing errors in assuming own or partner's HIV status. In particular, stressing that implicit disclosure is not disclosure. For HIV negative MSM who have multiple partners, condom use continues to be the most viable option for preventing HIV transmission and its importance needs to remain a clear message in behavioral interventions. HIV negative individuals who choose serosorting and not condom use as their means for reducing risks for HIV infection must recognize the importance of mutually monogamous relationships for protection against HIV. Additionally, within an intervention context, consideration needs to be given to the fact that some MSM who engage in serosorting will not be familiar with the term or even identify with the term.
From this review, we posit that public health messages pertaining to serosorting include clear statements regarding the difficulty of men who maintain high risk practices to ever test often enough for HIV to know they are not infected. HIV testing must be considered a medical diagnostic rather than an HIV prevention strategy. The ineffectiveness of HIV negative serosorting alone for HIV prevention further illustrates the pressing need for effective risk reduction counseling.
Limitations to this review include the challenges associated with summarizing studies from multiple literature domains. However, this process was necessary to fully appreciate and explore the many characteristics of serosorting that affect its effectiveness as an HIV prevention strategy. These challenges include having to cover a broad spectrum of research in areas relating to public health, psychology, and biology, and identifying information most relevant to serosorting. Moreover, given that serosorting occurs within a broader context of risk reduction strategies and risk behavior, it is difficult to ascertain the absolute effectiveness of serosorting. Finally, to better understand risk taking among ethnic minority MSM, further studying of their partner selection strategies is warranted.
Given the continued high rates of HIV infection among MSM, it is critical that public health service providers and the prevention messages they deliver continue to promote condom use when engaging in anal intercourse or alternatives to UAI. Serosorting among HIV negative men should be discouraged as the sole means of reducing HIV transmission risks. Addressing the limitations of using serosorting for protection against HIV is critical and may prevent further spread of HIV infection among MSM.
AIDS Care 1285
